Humoral Immunology Core Laboratory for AIDS Vaccine Research and Development
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $3,000,000 to $7,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- Robert Corno robert.corno@nih.gov (240) 669-5151
- Cesar Boggiano cesar.boggiano@nih.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The National Institutes of Health (NIH) is forecasting a new requirement for a Humoral Immunology Core Laboratory focused on AIDS Vaccine Research and Development. This procurement is classified under Biotechnology Research and Development (NAICS 541714) and is targeted for award on November 1, 2024. The contract will support critical research efforts in developing and analyzing humoral immune responses related to AIDS vaccine development.
While specific budget details are not provided, the contract will involve specialized laboratory services in immunology research. The primary point of contact is Robert Corno, a Contract Specialist at NIH, who can be reached at robert.corno@nih.gov or +1 (240) 669-5151. A secondary contact is Cesar Boggiano, Director of the Vaccine Research Program at the Division of AIDS - NIAID, who can be contacted at cesar.boggiano@nih.gov or (301) 496-4000 for additional information about the forecasted opportunity.
Forecast text
Humoral Immunology Core Laboratory for AIDS Vaccine Research and Development
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast